Home Infusion Therapy Devices Market Will Expand at a CAGR of 6.8% By 2025

According to the latest market report published by Persistence Market Research titled ‘Home Infusion Therapy Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),’ the global Home Infusion Therapy Devices market is expected to expand at a CAGR of 6.8% during the forecast period 2017–2025. Persistence Market Research delivers key insights and presents a revised forecast of the global Home Infusion Therapy Devices market for an eight year period from 2017 to 2025. The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry based demand driving factors, as well as the recent developments of key market participants. The global home infusion therapy devices market is projected to expand at a healthy CAGR of 6.8% in terms of value during the forecast period, revised from the previous CAGR of 5.5%, due to factors regarding which PMR offers useful insights in detail in this report.

Home infusion therapy facilitates the intravenous administration of medicines into the body of a patient with a needle or catheter. It is prescribed by physicians and administered by trained professionals and nurses. It is used when oral medication is not effective for the treatment of diseases. It reduces the time spent by patients in hospitals, nursing homes and clinics. It includes continuous and slow administration of drugs, antibiotics, nutrients and other fluids into the veins on a daily, weekly, or monthly basis, depending on the patient’s condition. Home infusion therapy is an effective and safe alternative against conventional hospitalization for treatment of diseases as it is provided in a friendly environment that helps in faster recovery from diseases. Home infusion therapy is employed in the treatment of diseases that are unresponsive to oral medication, such as cancer and gastrointestinal diseases. It is also used in the treatment of diabetes, cystic fibrosis, dehydration and acute infections. Home infusion therapy improves medication adherence and reduces unplanned hospitalization. Home infusion therapy includes total parenteral nutrition, infusion antibiotic therapy, chemotherapy and enteral therapy. Some major infusion devices used for administration of medicines are infusion pumps, intravenous equipment and others.

On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and the MEA. North America region dominated the global home infusion therapy devices market, which held around 34.7% of the global market in 2016 and is expected to continue to dominate the overall market partly due to higher awareness and entry of key players into the market by launching different products.

Vendor Insights

Companies are focusing on collaborations to develop new and more effective products. The product type segment of the home infusion therapy devices market will be boosted by its higher response rate and increasing investments in R&D leading to inorganic growth. The global home infusion therapy devices is highly fragmented owing to the presence of various companies such as B. Braun Melsungen AG., Becton, Dickinson and Company, Johnson & Johnson Private Limited (Animas Corporation), Fresenius Kabi AG, Terumo Corporation, F. Hoffmann-La Roche AG, Smith & Nephew, Pfizer Inc., Baxter International Inc. and Micrel Medical Devices S.A.

Request sample report @ https://www.persistencemarketresearch.com/samples/19111

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.